Placental Heat Shock Protein (HSP) Expression in Fetal Growth Restriction (FGR) Pregnancies: A Case–Control Immunohistochemistry Study
International Journal of Molecular Sciences · 27.05.2026 · 27 (11) · 4841
DOI: 10.3390/ijms27114841 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.05.2026. Verfasst von Athina A Samara und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Embryology, Faculty of Medicine, University of Thessaly, Biopolis, Mezourlo, 41110 Larissa, Greece. Hauptthemen laut MEDLINE: Fetal Growth Retardation, Placenta, HSP70 Heat-Shock Proteins, HSP90 Heat-Shock Proteins. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Special Account of Research Grants of the University of Thessaly.
Abstract (Originalsprache)
Fetal growth restriction (FGR) is frequently defined as the failure of the fetus to reach its genetically predetermined growth potential. Heat shock proteins (HSPs) are extreme-temperature-resistant molecules that help proteostasis. The aim of this prospective case–control immunohistochemistry study is to evaluate the expression of HSP90 and HSP70 in the placentas of pregnancies complicated with FGR and compare their levels with the control placentas of normal-growth pregnancies. A prospective case–control study was conducted including people undergoing singleton pregnancies who gave birth in a tertiary university hospital in Central Greece. Participants were divided into two equal groups: an FGR pregnancy group and a control group with normal growth. Immunohistochemistry of placental samples was assessed using anti-HSP90 alpha/beta antibody (clone F-8, Santa Cruz Biotechnology, Dallas, TX, USA) and anti-HSC70/HSP70 antibody (clone W27, sc-24, Santa Cruz Biotechnology, Dallas, TX, USA). A scoring system was created to quantify the expression of HSP90 and HSP70 in each sample, and the grade of staining was measured at four points. A total of 80 pregnant people were prospectively enrolled in our study, with 40 in each group. Both constitutive (HSP90β and HSC70/HSPA8) and stress-inducible (HSP90α and HSP70/HSPA1A/B) isoforms were analyzed. When comparing the total score of HSP expression, a statistically significant difference was observed for both HSP90 and HSP70. For HSP90 expression, only the Hofbauer cell’s stain was identified as a statistically significant independent factor, meaning that its positive expression was observed in Hofbauer cells. For HSP70 expression, only the staining of syncytiotrophoblasts was identified as an independent factor. FGR is a common pregnancy complication and a leading cause of stillbirth, neonatal mortality, and short- and long-term neonatal morbidity worldwide. Based on our findings, the lower expression levels of both HSP90 and HSP70 are associated with FGR, revealing a possible association with stress response in FGR pathophysiology. However, more robust data from larger-scale prospective studies are needed to elucidate the possible role of HSPs as potential FGR biomarkers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Embryology, Faculty of Medicine, University of Thessaly, Biopolis, Mezourlo, 41110 Larissa, Greece.
- Department of Pathology, Faculty of Medicine, University of Thessaly, Biopolis, Mezourlo, 41110 Larissa, Greece.
- Department of Obstetrics and Gynecology, Faculty of Medicine, University of Thessaly, Biopolis, Mezourlo, 41110 Larissa, Greece.
- Laboratory of Histology-Embryology, Department of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
ORCID-Profile: Athina A Samara, Michel B Janho, Theodoros Floros, Sofia Karachrysafi, Theodora Papamitsou, Sotirios Sotiriou
Förderung
- Special Account of Research Grants of the University of Thessaly
Zitieren
APA
Samara, A. A., Janho, M. B., Zacharouli, K., Floros, T., Ioannou, M., Garas, A., Karachrysafi, S., Papamitsou, T., Messini, C. I., Daponte, A., & Sotiriou, S. (2026). Placental Heat Shock Protein (HSP) Expression in Fetal Growth Restriction (FGR) Pregnancies: A Case–Control Immunohistochemistry Study. International Journal of Molecular Sciences, 27(11), 4841. https://doi.org/10.3390/ijms27114841
Vancouver
Samara AA, Janho MB, Zacharouli K, Floros T, Ioannou M, Garas A, et al. Placental Heat Shock Protein (HSP) Expression in Fetal Growth Restriction (FGR) Pregnancies: A Case–Control Immunohistochemistry Study. International Journal of Molecular Sciences. 2026;27(11):4841. doi:10.3390/ijms27114841
BibTeX
@article{Samara2026,
author = {Samara, Athina A and Janho, Michel B and Zacharouli, Konstantina and Floros, Theodoros and Ioannou, Maria and Garas, Antonios and Karachrysafi, Sofia and Papamitsou, Theodora and Messini, Christina I and Daponte, Alexandros and Sotiriou, Sotirios},
title = {Placental Heat Shock Protein (HSP) Expression in Fetal Growth Restriction (FGR) Pregnancies: A Case–Control Immunohistochemistry Study},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {11},
pages = {4841},
doi = {10.3390/ijms27114841}
}
EUVIMED